Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03911232Completed
Randomised, open-label trial of Sugammadex in laryngeal nerve injury (RLNI), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Restoration of neuromuscular function suppressed by rocuronium at 1 month. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03911232.